| Cytel Inc.. (10/6/17). "Press Release: Cytel Adds New Basel Location In Continued Expansion". |
2017-10-06 |
| Roche. (10/6/17). "Press Release: FDA Approves Roche cobas Zika as First Commercially-available Donor Screening Test for Zika virus". Basel. |
2017-10-06 |
| Tecan Group Ltd.. (10/6/17). "Press Release: Tecan Initiates Succession Process for the Board of Directors". Männedorf. |
2017-10-06 |
| Bruker Corporation. (10/6/17). "Press Release: Bruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal Diseases (IFD) into European Clinical Microbiology Markets". Belgrade. |
2017-10-06 |
| Progen Biotechnik GmbH. (10/5/17). "Press Release: Progen Acquires EuroProxima’s Research Antibodies". Heidelberg. |
2017-10-05 |
| Berlin Institute of Health. (10/5/17). "Press Release: Digital Health Accelerator from Berlin Health Innovations Starts with Three Teams". |
2017-10-05 |
| ProBioGen AG. (10/5/17). "Press Release: Chiome Bioscience Selects ProBioGen for GlymaxX Antibody Manufacturing Program". Berlin & Tokyo. |
2017-10-05 |
| Agena Bioscience, Inc.. (10/05/17). "Press Release: Agena Bioscience Bolsters MassARRAY Insights Reporting Network by Adding N-of-One". San Diego, CA. |
2017-10-05 |
| Apogenix AG. (10/5/17). "Press Release: Apogenix Granted Orphan Designation by the European Commission for Asunercept to Treat Myelodysplastic Syndromes". Heidelberg. |
2017-10-05 |
| Immatics Biotechnologies GmbH. (10/4/17). "Press Release: Immatics Receives USD 58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies". Tübingen & Houston, TX. |
2017-10-04 |
| Berlin Institute of Health. (10/4/17). "Press Release: BIH, Charité and MDC Sign Cooperation Agreement with Sanofi in Germany". |
2017-10-04 |
| Precision for Medicine. (10/4/17). "Press Release: Precision for Medicine Acquires Epiontis – a Leading Immune Monitoring and Epigenetic Technology Service Provider". Bethesda, MD & Berlin. |
2017-10-04 |
| BioNTech AG. (10/4/17). "Press Release: BioNTech Manufacturing Subsidiary, Eufets, Becomes BioNTech Innovative Manufacturing Services". Mainz. |
2017-10-04 |
| Siamab Therapeutics, Inc.. (10/4/17). "Press Release: Siamab Therapeutics and Boehringer Ingelheim Announce Strategic Cancer Immunology Discovery Collaboration to Develop Antibody Therapeutics Targeting Multiple Solid Tumors". Newton, MA. |
2017-10-04 |
| InGeneron Inc.. (10/4/17). "Press Release: InGeneron Appoints Angelo Moesslang as Chief Executive Officer". Houston, TX & Munich. |
2017-10-04 |
| Rentschler Biopharma SE. (10/4/17). "Press Release: Rentschler Biotechnologie GmbH Announces Transition into a European Corporation Called Rentschler Biopharma SE". Laupheim. |
2017-10-04 |
| Lunaphore Technologies S.A.. (10/4/17). "Press Release: Lunaphore Closes a CHF 6M Financing Round". Lausanne. |
2017-10-04 |
| Merck KGaA. (10/3/17). "Press Release: Merck Invests € 35 Million in Its Italian Biotech Manufacturing Site of Bari". Bari. |
2017-10-03 |
| Noxxon Pharma N.V.. (10/3/17). "Press Release: Noxxon Publishes Preclinical Proof-of-Concept Data for Lead Compound NOX-A12 in Combination with Checkpoint Inhibitors". Berlin. |
2017-10-03 |
| Global Bioenergies S.A.. (10/3/17). "Press Release: Global Bioenergies Strengthens Its Management Team". Évry. |
2017-10-03 |
| Lonza Group Ltd.. (10/3/17). "Press Release: Lonza to Acquire a U.S. Clinical Manufacturing Site to Support Ongoing Customer Demand". Basel. |
2017-10-03 |
| Roche. (10/3/17). "Press Release: Roche Launches Navify Tumor Board Solution to Provide Decision Support to Oncology Care Teams". Basel. |
2017-10-03 |
| Gilead Sciences, Inc.. (10/3/17). "Press Release: Gilead Sciences Completes Acquisition of Kite Pharma, Inc.". Foster City, CA. |
2017-10-03 |
| Cullinan Oncology, LLC. (10/3/17). "Press Release: Cullinan Oncology Secures $150 Million Series A Financing To Build Innovative Development Company". Cambridge, MA. |
2017-10-03 |
| Bruker Corporation. (10/2/17). "Press Release: Bruker Launches the Alpha II, the Second Generation of the World’s Most Popular Compact FTIR System for Chemical Analysis, Applied Markets and Industrial Quality Control". Billerica, MA. |
2017-10-02 |
| CRISPR Therapeutics AG. (10/2/17). "Press Release: CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer". Zug & Cambridge, MA. |
2017-10-02 |
| Global Bioenergies S.A.. (10/2/17). "Press Release: Publication of the half-year results to 30/06/2017. Net Loss for the Group of €7.8 Million in the First Half of 2017". Évry. |
2017-10-02 |
| Pieris Pharmaceuticals, Inc.. (10/2/17). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343". Boston, MA. |
2017-10-02 |
| Qiagen N.V.. (10/2/17). "Press Release: Qiagen Achieves ISO Certification for State-of-the-Art Quality in Forensics". Hilden & Germantown, MD. |
2017-10-02 |
| Roche. (9/29/17). "Press Release: FDA Grants Priority Review for Roche’s Perjeta (pertuzumab) for Adjuvant Treatment of HER2-positive Early Breast Cancer". Basel. |
2017-09-29 |
| Noxxon Pharma N.V.. (9/29/17). "Press Release: Noxxon Supervisory Board Elects Experienced US & EU Biotech Veteran Don deBethizy Chairman". Berlin. |
2017-09-29 |
| Novartis AG. (9/28/17). "Press Release: Novartis and UC Berkeley Collaborate to Tackle »Undruggable« Disease Targets". Basel. |
2017-09-28 |
| Evotec AG. (9/28/17). "Press Release: Evotec Invests in Exscientia to Advance AI-driven Drug Discovery". Hamburg & Dundee. |
2017-09-28 |
| Immatics Biotechnologies GmbH. (9/28/17). "Press Release: Immatics Initiates the First Phase I Clinical Trial of its Unique ACTengine Approach in Patients with Advanced Solid Cancers". Houston, TX & Tübingen. |
2017-09-28 |
| Streck, Inc.. (9/28/17). "Press Release: Streck Signs Distribution Agreement with Orgentec SASU". La Vista, NE. |
2017-09-28 |
| Roche. (9/28/17). "Press Release: Roche’s Ocrevus (ocrelizumab) Approved in Switzerland for Primary Progressive and Relapsing Forms of Multiple Sclerosis". Basel. |
2017-09-28 |
| ThromboGenics N.V.. (9/28/17). "Press Release: ThromboGenics Successfully Introduces New »Already-Diluted« Formulation of Jetrea (ocriplasmin) in the US". Leuven. |
2017-09-28 |
| Basilea Pharmaceutica Ltd.. (9/28/17). "Press Release: Basilea Announces License Agreement for Antibiotic Zevtera (ceftobiprole) with Shenzhen China Resources Gosun Pharmaceutical Co., Ltd.". Basel. |
2017-09-28 |
| Noxxon Pharma N.V.. (9/28/17). "Press Release: Noxxon Provides Update on Ongoing Phase 1/2 Clinical Trial with Lead Program NOX-A12". Berlin. |
2017-09-28 |
| Genedata AG. (9/27/17). "Press Release: Genedata Screener Strengthens Collaborative Research at Axxam". Basel. |
2017-09-27 |
| Endress+Hauser AG. (9/27/17). "Press Release: Endress+Hauser Inaugurates New Campus in Lyon". |
2017-09-27 |
| Oxford Immunotec Global plc. (9/27/17). "Press Release: Oxford Immunotec Announces Update in Patent Infringement Litigation". Oxford & Marlborough, MA. |
2017-09-27 |
| Bruker Corporation. (9/26/17). "Press Release: Bruker Announces Acquisition of Merlin to Add Selected Antibiotic Resistance and Susceptibility Testing to its MALDI Biotyper Microbial Identification Platform". Bremen. |
2017-09-26 |
| Juno Therapeutics, Inc.. (9/26/17). "Press Release: Juno Therapeutics Closes Follow-on Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares". Seattle, WA. |
2017-09-26 |
| Roivant Sciences GmbH. (9/26/17). "Press Release: Axovant Announces Negative Topline Results of Intepirdine Phase 3 MINDSET Trial in Alzheimer’s Disease". Basel. |
2017-09-26 |
| AvroBio, Inc.. (9/26/17). "Press Release: AvroBio, Inc. Appoints Katina Dorton as Chief Financial Officer". Cambridge, MA. |
2017-09-26 |
| Novartis AG. (9/22/17). "Press Release: Novartis and The Max Foundation Transform Pioneering Cancer Access Program for People in Lower-income Countries". Basel. |
2017-09-22 |
| Juno Therapeutics, Inc.. (9/21/17). "Press Release: Juno Therapeutics Prices $250 Million Follow-on Offering". Seattle, WA. |
2017-09-21 |
| Juno Therapeutics, Inc.. (9/21/17). "Press Release: Juno Therapeutics Opens New Headquarters and Research Center". Seattle, WA. |
2017-09-21 |
| Humabs BioMed S.A.. (9/21/17). "Press Release: Data on Novel Bi-specific Antibody to Treat Zika Virus Infection Published in »Cell«". |
2017-09-21 |
| Abivax S.A.. (9/20/17). "Press Release: Abivax First-half 2017 Financial Results and Update". Paris. |
2017-09-20 |
| Roivant Sciences GmbH. (9/20/17). "Press Release: Roivant Sciences Launches Datavant to Improve Clinical Trials with Artificial Intelligence". San Francisco, CA & Basel. |
2017-09-20 |
| Novartis AG. (9/20/17). "Press Release: Novartis Drug Rydapt (midostaurin) Receives EU Approval for Newly Diagnosed FLT3-mutated Acute Myeloid Leukemia (AML) and Three Types of Advanced Systemic Mastocytosis (SM)". Basel. |
2017-09-20 |
| Nabriva Therapeutics plc. (9/19/17). "Press Release: Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $80 Million". Dublin & King of Prussia, PA. |
2017-09-19 |
| Transgene S.A.. (9/19/17). "Press Release: First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers". Strasbourg. |
2017-09-19 |
| Nabriva Therapeutics plc. (9/18/17). "Press Release: Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares". Dublin & King of Prussia, PA. |
2017-09-18 |
| Nabriva Therapeutics plc. (9/18/17). "Press Release: Nabriva Therapeutics Announces Positive Topline Results from Global, Phase 3 Clinical Trial Evaluating IV and Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia". Dublin & King |
2017-09-18 |
| Roivant Sciences GmbH. (9/18/17). "Press Release: Urovant Sciences Appoints Keith A. Katkin as Chief Executive Officer". Basel. |
2017-09-18 |
| Bruker Corporation. (9/18/17). "Press Release: Bruker Launches the timsTOF Pro Mass Spectrometer to Enable the Revolutionary PASEF Method for Next-Generation Proteomics". Dublin. |
2017-09-18 |
| ThromboGenics N.V.. (9/18/17). "Press Release: ThromboGenics Regains Global Rights to Jetrea (ocriplasmin)". Leuven. |
2017-09-18 |
| High-Tech Gründerfonds Management GmbH. (9/18/17). "Press Release: Evonik Is Investing in Numaferm, a Specialist in the Biotechnological Production of Peptides". |
2017-09-18 |
| Ncardia. (9/18/17). "Press Release: Ncardia Established Following Pluriomics Axiogenesis Merger". Gosselies, Cologne, Leiden & Philadelphia, PA. |
2017-09-18 |
| Tolremo Therapeutics AG. (9/18/17). "Press Release: Tolremo Therapeutics AG – Preventing Drug Resistance in Cancer Therapy". Zürich. |
2017-09-18 |
| Bayer AG. (9/15/17). "Press Release: Bayer Receives Positive CHMP Opinion for Rivaroxaban 10 mg Once Daily for the Extended Prevention of Venous Thromboembolism [Not intended for U.S. and UK Media]". Berlin. |
2017-09-15 |
| Selexis S.A.. (9/15/17). "Press Release: Selvita Demonstrates Strong Revenue Growth in H1 2017". Kraków. |
2017-09-15 |
| Santhera Pharmaceuticals Holding AG. (9/15/17). "Press Release: Santhera Receives Negative Opinion from the CHMP for Its Marketing Authorization Application for Raxone in DMD and Intends to Appeal this Opinion". Liestal. |
2017-09-15 |
| Boehringer Ingelheim. (9/15/17). "Press Release: Boehringer Ingelheim Receives Positive CHMP Opinion for Adalimumab Biosimilar Cyltezo". Ingelheim. |
2017-09-15 |
| AB Sciex (d/b/a Sciex). (9/15/17). "Press Release: Sciex Announces the Appointment of Inese Lowenstein as President. Former President Jean-Paul Mangeolle to Retire". Framingham, MA. |
2017-09-15 |
| Adecco Group AG. (9/14/17). "Press Release: The Adecco Group Announces Acquisition of BioBridges". Zurich. |
2017-09-14 |
| Bayer AG. (9/14/17). "Press Release: Bayer and Ginkgo Bioworks Join Forces for Sustainable Agriculture, Forming New Company with USD 100 million Series A". Leverkusen & Boston, MA. |
2017-09-14 |
| Evotec AG. (9/14/17). "Press Release: Evotec and MaRS Innovation Establish Academic Bridge »LAB150« in Toronto". Hamburg. |
2017-09-14 |
| Leukocare AG. (9/14/17). "Press Release: Leukocare Continues to Expand and Invests in Research and Development". Munich. |
2017-09-14 |
| Lipotype GmbH. (9/13/17). "Press Release: Lipid Analysis for Early Stages of Drug Discovery – Customer Reference Flagship VentureLabs". |
2017-09-13 |
| Sophia Genetics S.A.. (9/13/17). "Press Release: Sophia Genetics Raises $30 Million in Series D Funding to Accelerate Its Mission of Democratizing Data-driven Medicine Worldwide". St. Sulpice. |
2017-09-13 |
| Genenta Science S.r.l.. (9/13/17). "Press Release: Genenta Raised Other $8,4 Million (€7 Million) in the Second Round of Financing
- Total Raised in Two Rounds, $20,4 Million (€17 Million) -". Milano. |
2017-09-13 |
| Roivant Sciences GmbH. (9/13/17). "Press Release: Roivant Strengthens Executive Team with Key Hires and Promotions. Former GC of Pfizer Allen Waxman Joins Roivant". Basel. |
2017-09-13 |
| Affimed N.V.. (9/13/17). "Press Release: Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer". Heidelberg. |
2017-09-13 |
| BC Platforms. (9/13/17). "Press Release: BC Platforms Launches Unique Global Genomics and Clinical Data Analytics Resource". |
2017-09-13 |
| Transgene S.A.. (9/13/17). "Press Release: First Half-year 2017 in Line with Our Objectives – All Clinical Programs Progressing and New Collaboration Agreements Signed". Strasbourg. |
2017-09-13 |
| GreenLight Biosciences, Inc.. (9/13/17). "Press Release: GreenLight Biosciences Announces Series D Financing, Unveils RNA Strategy". Medford, MA. |
2017-09-13 |
| Bayer AG. (9/12/17). "Press Release: Wolfgang Nickl to Be New Chief Financial Officer at Bayer AG". Leverkusen. |
2017-09-12 |
| Berkeley Lights, Inc.. (9/12/17). "Press Release: Berkeley Lights Announces Strategic Project with Bayer Focused on Cell Line Development and Antibody Discovery". Emeryville, CA. |
2017-09-12 |
| DNA Script. (9/12/17). "Press Release: DNA Script Raises €11 Million ($13 Million) in Series A Financing Led by Illumina Ventures to Advance Development of Its DNA Synthesis Technology". Paris. |
2017-09-12 |
| Ayoxxa Biosystems GmbH. (9/11/17). "Press Release: Ayoxxa Introduces Lunaris, Its Advanced Fully Integrated Low-volume Beads-on-a-Chip Multiplex Protein Analysis System". Cologne. |
2017-09-11 |
| Bayer AG. (9/11/17). "Press Release: Bayer and Vanderbilt University Medical Center Collaborate to Develop Therapies against Kidney Diseases [Not intended for U.S. and UK Media]". Berlin. |
2017-09-11 |
| NMI TT Pharmaservices. (9/11/17). "Press Release: NMI TT Takes Over Global Zeptosens RPPA Chip Supply". Reutlingen & Berlin. |
2017-09-11 |
| Evotec AG. (9/8/17). "Press Release: European Investment Bank Supports Evotec’s Innovate Strategy with EUR 75 M Loan". Hamburg & Brussels. |
2017-09-08 |
| AB Sciex (d/b/a Sciex). (9/8/17). "Press Release: Sciex Launches the Topaz LC-MS/MS System for Clinical Diagnostics in Europe". Warrington, UK. |
2017-09-08 |
| Leap Therapeutics, Inc.. (9/8/17). "Press Release: Leap Therapeutics Announces Collaboration with EORTC to Evaluate DKN-01 in Combination with PD-L1 Cancer Immunotherapy and Chemotherapy In Esophagogastric and Biliary Tract Cancers". Cambridge, MA. |
2017-09-08 |
| Roche. (9/8/17). "Press Release: Roche Announces Progress in Biomarker Science in Cancer Immunotherapy at the European Society for Medical Oncology Congress". Basel. |
2017-09-08 |
| Epigenomics AG. (9/8/17). "Press Release: Epigenomics AG Issues Convertible Bonds". Berlin & Germantown, MD. |
2017-09-08 |
| Evotec AG. (9/7/17). "Press Release: Evotec and Abivax Enter into Strategic Collaboration to Develop Novel Antiviral Agents". Hamburg & Paris. |
2017-09-07 |
| BRAIN AG. (9/7/17). "Press Release: BRAIN AG Wins New Long-term Oriented Investor by Way of a Capital Increase. DAH Beteiligungs GmbH Is New, Long-term Oriented Investor of BRAIN AG Supporting Its Growth Strategy". Zwingenberg. |
2017-09-07 |
| BRAIN AG. (9/7/17). "Press Release: BRAIN AG Resolves Upon Capital Increase – New Long-term Investor Subscribes All New Shares [Ad-hoc News]". Zwingenberg. |
2017-09-07 |
| Bayer AG. (9/7/17). "Press Release: Bayer Submits Marketing Authorization Application for BAY94-9027 for the Treatment of Hemophilia A in the EU [Not intended for U.S. and UK Media]". Berlin. |
2017-09-07 |
| Boehringer Ingelheim. (9/7/17). "Press Release: Boehringer Ingelheim and Gubra Collaborate to Develop Next Generation Obesity Treatments". Ingelheim & Hørsholm. |
2017-09-07 |
| Markes International Ltd.. (9/7/17). "Press Release: Markes International Opens New Chinese Subsidiary in Shanghai". |
2017-09-07 |
| InflaRx GmbH. (9/7/17). "Press Release: InflaRx Reports Topline Phase IIa Clinical Results of IFX-1 for the Treatment of Hidradenitis Suppurativa". Jena. |
2017-09-07 |
| MorphoMed GmbH. (9/7/17). "Press Release: MorphoMed – New Start-up Focusing on Next-generation Tissue Engineering in Vienna". |
2017-09-07 |
| Merck & Co., Inc.. (9/6/17). "Press Release: Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology". Kenilworth, NJ & Munich. |
2017-09-06 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 29 30 31 ... 45 46 47 
Date
![Picture [iito] No Content Marketing 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
